#26: Charity and Non-Profit Platform Rally.org Obtained $7.9 Million from Investors
Published by
Scott Jordan
on
In a recently published White Paper, SJA profiled how emerging growth biotechnology companies can leverage Crowdfunding to raise non-dilutive capital from investors with "Compassionate Use" goals (see excerpt below). Recently, a charity and non-profit Crowdfunding platform, Rally.org, raised $7.9 million from investors including Greylock Partners and Google Ventures.
http://www.digitaltrends.com/social-media/rally-org-raises-7-9-million-crowdfundings-tipping-point/
From SJA White Paper:
"In many cases individuals may not come to expect their financial investment to solely yield monetary gains. Startups wanting to explore Crowdfunding might attain success through “medical interest networks” such as patient advocacy groups, foundations or clinical societies that are dedicated to a certain condition or diseases. The entertainment industry has demonstrated success in appealing to hobbyists and aficionados (often offering nothing more than free movie tickets or screenplays), and a similar case may be made for healthcare companies attracting those with philanthropic goals. Investors at the lower end of the spectrum ($1,000 - $5,000) may see investments as glorified donations; a way to further a good cause.
Healthcare is one of the few spaces where an investor can see a direct quality of life improvement through a financial pledge. It is also one of the few spaces so obviously rooted in moral tenets; the power and interests of patients and their families. This will be important especially for those companies looking for effective treatments in fields where there are no therapies available (i.e., Alzheimer’s disease, Huntington’s disease)."
http://www.digitaltrends.com/social-media/rally-org-raises-7-9-million-crowdfundings-tipping-point/
From SJA White Paper:
"In many cases individuals may not come to expect their financial investment to solely yield monetary gains. Startups wanting to explore Crowdfunding might attain success through “medical interest networks” such as patient advocacy groups, foundations or clinical societies that are dedicated to a certain condition or diseases. The entertainment industry has demonstrated success in appealing to hobbyists and aficionados (often offering nothing more than free movie tickets or screenplays), and a similar case may be made for healthcare companies attracting those with philanthropic goals. Investors at the lower end of the spectrum ($1,000 - $5,000) may see investments as glorified donations; a way to further a good cause.
Healthcare is one of the few spaces where an investor can see a direct quality of life improvement through a financial pledge. It is also one of the few spaces so obviously rooted in moral tenets; the power and interests of patients and their families. This will be important especially for those companies looking for effective treatments in fields where there are no therapies available (i.e., Alzheimer’s disease, Huntington’s disease)."